USFDA inspects FDC's manufacturing facility at Roha, Maharashtra

FDC Limited has informed to the exchanges regarding USFDA inspection at Company’s manufacturing facility located at Roha, Dist.- Raigad, Maharashtra, India.

According to the regulatory filing, the company informed that its manufacturing unit located at Roha, Dist.- Raigad that manufactures Active Pharmaceutical Ingredient (APIs) products has been inspected by US FDA from March 20, 2023 to March 24, 2023.

“The said audit has been successfully completed by the US FDA with “No observations” (Zero 483’s)”, the company said on Monday.

It is informed that the Active Pharmaceutical Ingredients (API’s) product manufactured at the above facility continues to be marketed in USA.

On Monday, at around 1:24 PM, shares of FDC Limited were trading higher by 0.41% at Rs255.75 per share on the BSE.

Top stories
Company

Aurobindo Pharma to Consider Share Buyback Worth Rs 750 Cr

3 mins read . 19 Jul 2024 . 05:22 AM

Company

3 mins read . 19 Jul 2024 . 05:19 AM

Related Blogs
blog-logo

Share Market

blog-logo

15 mins read . 08 Jul 2024

Best Oil & Gas Stocks in India

  • 1 people read
blog-logo

Share Market

blog-logo

11 mins read . 08 Jul 2024

How to Withdraw SIP Amount?

  • 1 people read
Kickstart your equities journey today You've got this
By submitting this I agree to the terms & conditions